IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAZZIOTTI, Gherardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.797
AS - Asia 1.988
EU - Europa 1.848
SA - Sud America 343
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 9.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.726
SG - Singapore 732
CN - Cina 717
UA - Ucraina 427
PL - Polonia 364
BR - Brasile 293
DE - Germania 270
HK - Hong Kong 186
FI - Finlandia 168
FR - Francia 136
GB - Regno Unito 123
IT - Italia 120
VN - Vietnam 89
RU - Federazione Russa 78
TR - Turchia 68
IN - India 66
IE - Irlanda 65
BD - Bangladesh 42
CA - Canada 42
AR - Argentina 21
CZ - Repubblica Ceca 19
MX - Messico 19
SE - Svezia 18
ZA - Sudafrica 17
ES - Italia 13
IQ - Iraq 13
NL - Olanda 12
ID - Indonesia 11
BE - Belgio 10
JP - Giappone 10
NG - Nigeria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
EU - Europa 7
CL - Cile 6
IR - Iran 6
MA - Marocco 6
AU - Australia 5
JM - Giamaica 5
KE - Kenya 5
KR - Corea 5
AT - Austria 4
PE - Perù 4
PK - Pakistan 4
RO - Romania 4
AL - Albania 3
CO - Colombia 3
EC - Ecuador 3
NP - Nepal 3
AM - Armenia 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KW - Kuwait 2
LT - Lituania 2
PA - Panama 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NR - Nauru 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
Totale 9.036
Salva come PNG Salva come JPEG
Città #
Fairfield 644
Ashburn 516
Singapore 384
Warsaw 358
Houston 342
Woodbridge 317
Jacksonville 290
Seattle 248
Cambridge 234
Ann Arbor 215
San Jose 209
Wilmington 199
Beijing 192
Hong Kong 186
The Dalles 133
Chandler 124
Princeton 118
Nanjing 103
New York 98
Helsinki 96
Los Angeles 74
Dublin 64
Lauterbourg 59
Istanbul 57
Dallas 51
Nanchang 51
Munich 48
Moscow 38
Des Moines 36
San Diego 31
Shenyang 31
Brescia 29
Shanghai 27
Buffalo 26
Chicago 25
Council Bluffs 25
San Francisco 24
São Paulo 24
Ho Chi Minh City 23
Orem 23
Redondo Beach 22
Milan 21
Changsha 20
Jiaxing 20
Tianjin 20
London 17
Mumbai 17
Santa Clara 17
Hebei 16
Washington 16
Hanoi 15
Toronto 15
Atlanta 14
Boardman 14
Brno 14
Manchester 14
Poplar 14
Rio de Janeiro 14
Turku 14
Denver 13
Dong Ket 12
Kunming 12
Hangzhou 11
Brooklyn 10
Brussels 10
Tokyo 10
Augusta 9
Chennai 9
Montreal 9
San Mateo 9
Abuja 8
Dhaka 8
Johannesburg 8
Stockholm 8
Ankara 7
Belo Horizonte 7
Cassina de' Pecchi 7
Charlotte 7
Lancaster 7
Mexico City 7
Philadelphia 7
Phoenix 7
Baghdad 6
Curitiba 6
Greifswald 6
Jakarta 6
Leawood 6
Paris 6
Tashkent 6
Brasília 5
Frankfurt am Main 5
Jinan 5
Kingston 5
Lappeenranta 5
Monmouth Junction 5
Querétaro 5
Vancouver 5
Ardabil 4
Bari 4
Boston 4
Totale 6.382
Salva come PNG Salva come JPEG
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 353
Elevated intraocular pressure in patients with acromegaly 342
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 189
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 187
Growth hormone deficiency in treated acromegaly 181
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 173
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 166
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 155
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 152
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 150
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 148
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 148
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 148
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 145
Cardiovascular risk in aging and obesity: is there a role for GH. 144
Growth hormone deficiency in the adult. 143
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 140
Prevalence of vertebral fractures in men with acromegaly 138
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 138
Octreotide for acromegaly treatment: a reappraisal. 138
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 138
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 137
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 136
New understanding and treatments for osteoporosis. 136
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 136
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 134
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 133
Glucocorticoids and the regulation of growth hormone secretion. 132
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 132
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 129
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 127
Cushing's syndrome and bone. 123
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 123
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 122
GH deficiency in the adult and bone. 121
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 120
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 119
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 117
Commentary:Postsurgical monitoring of acromegaly 117
Growth hormone replacement therapy and fracture risk 117
Osteoporosis in HIV patients: an emerging clinical issue 116
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 116
Subclinical thyrotoxicosis and bone 116
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 115
Vertebral fractures in males with prolactinoma. 115
Pituitary diseases and bone 114
Growth hormone, insulin like growth factors, and the skeleton 113
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 112
Glucocorticoid-induced osteoporosis: an update. 112
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 110
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 109
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 108
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 108
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 106
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 105
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 105
Prevention and treatment of glucocorticoid-induced osteoporosis. 104
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 102
Resistance to somatostatin analogs in acromegaly: an evolving concept? 102
Glucocorticoid-induced osteoporosis and parathyroid hormone. 98
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 98
Drug-induced osteoporosis:mechanism and clinical implications 97
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 89
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 84
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 75
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 69
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 68
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 62
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 44
null 13
Totale 9.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022511 43 105 10 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024584 28 14 42 54 42 114 26 17 136 6 6 99
2024/20251.109 6 3 12 156 135 91 58 51 144 43 268 142
2025/20262.345 261 297 144 261 324 175 389 53 140 149 127 25
Totale 9.105